Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)
Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)
The current gold standard for treatment of chronic hepatitis C (CHC) patients is with
 pegylated interferon plus ribavirin. Drug administration accuracy and ease of use will
 definitely determine treatment effectiveness. This is the idea behind the development and
 usage of the PegPen. The goal of this study is to determine the satisfaction grade with this
 novel device.
Enrollment of patients will occur in a sequential order of treatment initiation.
Inclusion Criteria:

 -  Adult patients with hepatitis C

 Exclusion Criteria:

 -  According to the products' labeling.